Common polymorphisms in the microsomal epoxide hydrolase and N-acetyltransferase 2 genes in association with inflammatory bowel disease in the Danish population

European Journal of Gastroenterology and Hepatology

Volumn 23, Issue 3, 2011, Pages 269-274

  Ernst, Anja ^a   Andersen, Vibeke ^b   Østergaard, Mette ^b   Jacobsen, Bent A ^a   Pedersen, Inge S ^a   Drewes, Asbjørn M ^a   Okkels, Henrik ^a   Krarup, Henrik B ^a  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

^b VIBORG HOSPITAL   (Denmark)

Author keywords

Crohn's disease; detoxification; inflammatory bowel disease; microsomal epoxide hydrolase; N acetyltransferase 2; smoking; ulcerative colitis

Indexed keywords

ARYLAMINE ACETYLTRANSFERASE; AZATHIOPRINE; EPOXIDE HYDROLASE;

ADULT; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SMOKING HABIT; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; ARYLAMINE N-ACETYLTRANSFERASE; AZATHIOPRINE; CHRONIC DISEASE; COHORT STUDIES; DENMARK; EPOXIDE HYDROLASES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MICROSOMES; MIDDLE AGED; POLYMORPHISM, GENETIC; PREVALENCE; RISK FACTORS; YOUNG ADULT;

EID: 79951945133     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e3283438a44     Document Type: Article

References (32)

1. Noomen CG, Hommes DW, Fidder HH. Update on genetics in inflammatory disease. Best Pract Res Clin Gastroenterol 2009; 23:233-243.
2. Melum E, Franke A, Karlsen TH. Genome-wide association studies-a summary for the clinical gastroenterologist. World J Gastroenterol 2009; 15:5377-5396.
3. Silverberg MS, Cho JH, Rioux JD, McGovern DP, Wu J, Annese V, et al. Ulcerative colitis loci on chromosomes 1p36 and 12q15 identified by genome-wide association study. Nat Genet 2009; 41:216-220.
4. Torkamani A, Topol EJ, Schork NJ. Pathway analysis of seven common diseases assessed by genome-wide association. Genomics 2008; 92:265-272.
5. Xavier RJ, Rioux JD. Genome-wide association studies: a new window into immune-mediated diseases. Nat Rev Immunol 2008; 8:631-643.
6. Barrett JC, Hansoul S, Nicolae DL, Cho JH, Duerr RH, Rioux JD, et al. Genome-wide association defines more than thirty distinct susceptibility loci for Crohn's disease. Nat Genet 2008; 40:955-962.
7. Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, Hunter DJ, et al. Finding the missing heritability of complex diseases. Nature 2009; 461:747-753.
8. Lih-Brody L, Powell SR, Collier KP, Reddy GM, Cerchia R, Kahn E, et al. Increased oxidative stress and decreased antioxidant defenses in mucosa of inflammatory bowel disease. Dig Dis Sci 1996; 41:2078-2086. (Pubitemid 26366811)
9. Rezaie A, Parker RD, Abdollahi M. Oxidative stress and pathogenesis of inflammatory bowel disease: an epiphenomenon or the cause? Dig Dis Sci 2007; 52:2015-2021.
10. Liska DJ. The detoxification enzyme systems. Altern Med Rev 1998; 3:187-198. (Pubitemid 128709128)
11. Fretland AJ, Omiecinski CJ. Epoxide hydrolases: biochemistry and molecular biology. Chem Biol Interact 2000; 129:41-59. (Pubitemid 32061053)
12. Decker M, Arand M, Cronin A. Mammalian epoxide hydrolases in xenobiotic metabolism and signalling. Arch Toxicol 2009; 83:297-318.
13. Gsur A, Zidek T, Schnattinger K, Feik E, Haidinger G, Hollaus P, et al. Association of microsomal epoxide hydrolase polymorphisms and lung cancer risk. Br J Cancer 2003; 89:702-706. (Pubitemid 37076177)
14. Hassett C, Aicher L, Sidhu JS, Omiecinski CJ. Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants. Hum Mol Genet 1994; 3:421-428. (Pubitemid 24083901)
15. Omiecinski CJ, Hassett C, Hosagrahara V. Epoxide hydrolase - polymorphism and role in toxicology. Toxicol Lett 2000; 112-113:365-370. (Pubitemid 30138145)
16. Sarmanova J, Tynkova L, Susova S, Gut I, Soucek P. Genetic polymorphisms of biotransformation enzymes: allele frequencies in the population of the Czech Republic. Pharmacogenetics 2000; 10:781-788. (Pubitemid 32042830)
17. Sim E, Payton M, Noble M, Minchin R. An update on genetic, structural and functional studies of arylamine N-acetyltransferases in eucaryotes and procaryotes. Hum Mol Genet 2000; 9:2435-2441.
18. Sim E, Westwood I, Fullam E. Arylamine N-acetyltransferases. Expert Opin Drug Metab Toxicol 2007; 3:169-184.
19. Hein DW. Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesis. Mutat Res 2002; 506-507:65-77. (Pubitemid 35286541)
20. Pawlik A, Ostanek L, Brzosko I, Gawroska-Szklarz B, Brzosko M, Dabrowska-Zamojcin E. Increased genotype frequency of N-acetyltransferase 2 slow acetylation in patients with rheumatoid arthritis. Clin Pharmacol Ther 2002; 72:319-325.
21. Kiyohara C, Washio M, Horiuchi T, Tada Y, Asami T, Ide S, et al. Cigarette smoking, N-acetyltransferase 2 polymorphisms and systemic lupus erythematosus in a Japanese population. Lupus 2009; 18:630-638.
22. Machida H, Tsukamoto K, Wen CY, Shikuwa S, Isomoto H, Mizuta Y, et al. Crohn's disease in Japanese is associated with a SNP-haplotype of N-acetyltransferase 2 gene. World J Gastroenterol 2005; 11:4833-4837. (Pubitemid 41223292)
23. Binder V, Both H, Hansen PK, Hendriksen C, Kreiner S, Torp-Pedersen K. Incidence and prevalence of ulcerative colitis and Crohn's disease in the County of Copenhagen, 1962 to 1978. Gastroenterology 1982; 83:563-568.
24. Kuznetsov IB, McDuffie M, Moslehi R. A web server for inferring the human N-acetyltransferase-2 (NAT2) enzymatic phenotype from NAT2 genotype. Bioinformatics 2009; 25:1185-1186.
25. Cuthbert AP, Fisher SA, Lewis CM, Mathew CG, Sanderson J, Forbes A. Genetic association between EPHX1 and Crohn's disease: population stratification, genotyping error, or random chance? Gut 2004; 53:1386.
26. Peters WH, Van der Logt EM, Te Morsche RH, Roelofs HM, De Jong DJ, Naber TH. No genetic association between EPHX1 and Crohn's disease. Gut 2005; 54:1659-1660. (Pubitemid 41531788)
27. Sabbagh A, Darlu P, Vidaud M. Evaluating NAT2PRED for inferring the individual acetylation status from unphased genotype data. BMC Med Genet 2009; 10:148.
28. Mahid SS, Colliver DW, Crawford NP, Martini BD, Doll MA, Hein DW, et al. Characterization of N-acetyltransferase 1 and 2 polymorphisms and haplotype analysis for inflammatory bowel disease and sporadic colorectal carcinoma. BMC Med Genet 2007; 8:28.
29. Chen M, Xia B, Chen B, Guo Q, Li J, Ye M, Hu Z. N-acetyltransferase 2 slow acetylator genotype associated with adverse effects of sulfasalazine in the treatment of inflammatory bowel disease. Can J Gastroenterol 2007; 21:155-158. (Pubitemid 47061612)
30. Brant SR, Picco MF, Achkar JP, Bayless TM, Kane SV, Brzezinski A, et al. Defining complex contributions of NOD2/CARD15 gene mutations, age at onset, and tobacco use on Crohn's disease phenotypes. Inflamm Bowel Dis 2003; 9:281-289. (Pubitemid 37161747)
31. Ernst A, Jacobsen B, Ostergaard M, Okkels H, Andersen V, Dagiliene E, et al. Mutations in CARD15 and smoking confer susceptibility to Crohn's disease in the Danish population. Scand J Gastroenterol 2007; 42:1445-1451. (Pubitemid 350125541)
32. Halfvarson J, Jess T, Magnuson A, Montgomery SM, Orholm M, Tysk C, et al. Environmental factors in inflammatory bowel disease: a co-twin control study of a Swedish-Danish twin population. Inflamm Bowel Dis 2006; 12:925-933. (Pubitemid 44498280)